全外显子组测序助力儿童肾移植受者精准医疗
该研究对104例儿童肾移植受者进行全外显子组测序,发现32.7%的患者存在已知CKD致病基因变异,其中尿路结石病、肾囊性纤毛病和激素抵抗性肾病综合征检出率较高;5例患者的基因诊断影响了临床管理。
要点
- 儿童肾移植受者中WES诊断率约32.7%,近1/3可明确遗传病因
- 尿路结石病、肾囊性纤毛病和激素抵抗性肾病综合征检出率最高
- 基因诊断有助于指导移植患者及活体亲属供者的管理
核心结论
- 近三分之一的儿童肾移植受者可通过WES鉴定出肾脏病的遗传病因。
- WES获得的分子遗传学诊断对5例患者的临床管理产生了影响。
研究设计与样本
- 回顾性队列研究,纳入2007至2017年在波士顿儿童医院接受肾移植的104例患者。
- 对患者进行全外显子组测序,分析约400个已知CKD致病基因中的可能有害变异。
主要发现
- 104例受者中34例(32.7%)检出CKD遗传病因。
- 尿路结石病3/3例、肾囊性纤毛病7/9例、激素抵抗性肾病综合征9/21例、先天性肾脏和尿路畸形10/55例、慢性肾小球肾炎1/7例检出分子诊断。
- 不明病因终末期肾病9例中4例获得分子诊断。
- WES相关分子遗传学诊断对5例患者的临床管理有影响。
临床怎么用
- 对儿童肾移植受者考虑WES以明确遗传病因。
- 基因诊断结果可用于指导移植患者及潜在活体亲属供者的管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whole-exome sequencing (WES) finds a CKD-related mutation in approximately 20% of patients presenting with CKD before 25 years of age. Although provision of a molecular diagnosis could have important implications for clinical management, evidence is lacking on the diagnostic yield and clinical utility of WES for pediatric renal transplant recipients. METHODS: To determine the diagnostic yield of WES in pediatric kidney transplant recipients, we recruited 104 patients who had received a transplant at Boston Children's Hospital from 2007 through 2017, performed WES, and analyzed results for likely deleterious variants in approximately 400 genes known to cause CKD. RESULTS: By WES, we identified a genetic cause of CKD in 34 out of 104 (32.7%) transplant recipients. The likelihood of detecting a molecular genetic diagnosis was highest for patients with urinary stone disease (three out of three individuals), followed by renal cystic ciliopathies (seven out of nine individuals), steroid-resistant nephrotic syndrome (nine out of 21 individuals), congenital anomalies of the kidney and urinary tract (ten out of 55 individuals), and chronic glomerulonephritis (one out of seven individuals). WES also yielded a molecular diagnosis for four out of nine individuals with ESRD of unknown etiology. The WES-related molecular genetic diagnosis had implications for clinical care for five patients. CONCLUSIONS: Nearly one third of pediatric renal transplant recipients had a genetic cause of their kidney disease identified by WES. Knowledge of this genetic information can help guide management of both transplant patients and potential living related donors.
引用
- Mann N, Braun DA, Amann K, et al. Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. J Am Soc Nephrol. 2019. PMID: 30655312. doi:10.1681/ASN.2018060575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。